Characteristics of non-obese non-alcoholic fatty liver disease: Effect of genetic and environmental factors

被引:60
|
作者
Honda, Yasushi [1 ]
Yoneda, Masato [1 ]
Kessoku, Takaomi [1 ]
Ogawa, Yuji [1 ]
Tomeno, Wataru [1 ]
Imajo, Kento [1 ]
Mawatari, Hironori [1 ]
Fujita, Koji [1 ]
Hyogo, Hideyuki [2 ]
Ueno, Takato [4 ]
Chayama, Kazuaki [3 ]
Saito, Satoru [1 ]
Nakajima, Atsushi [1 ]
Hotta, Kikuko [5 ]
机构
[1] Yokohama City Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Yokohama, Kanagawa, Japan
[2] JA Hiroshima Gen Hosp, Hiroshima, Japan
[3] Hiroshima Univ, Grad Sch Biomed Sci, Dept Med & Mol Sci, Hiroshima, Japan
[4] Kurume Univ, Res Ctr Innovat Canc Therapy, Kurume, Fukuoka, Japan
[5] Osaka Univ Hosp, Dept Med Innovat, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan
关键词
non-alcoholic fatty liver disease; non-obese non-alcoholic fatty liver disease; PNPLA3; type 2 diabetes mellitus; TRIGLYCERIDE TRANSFER PROTEIN; GENOME-WIDE ASSOCIATION; MORBIDLY OBESE PATIENTS; GASTRIC BYPASS-SURGERY; METABOLIC SYNDROME; PNPLA3; STEATOHEPATITIS; POLYMORPHISMS; POPULATION; PREVALENCE;
D O I
10.1111/hepr.12648
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AimThere are a considerable number of patients with non-obese non-alcoholic fatty liver disease (NAFLD). However, the clinical characteristics of non-obese NAFLD is not fully understood. We investigated genetic and other clinical parameters in non-obese and obese NAFLD. MethodsThe single nucleotide polymorphism rs738409 in the patatin-like phospholipase 3 gene (PNPLA3) was genotyped by the Invader assay in 540 NAFLD patients (134 non-obese and 406 obese) and 1012 control subjects (782 non-obese and 230 obese). All NAFLD patients underwent liver biopsy. Odds ratios were calculated by multiple logistic regression analysis using age, sex, body mass index (BMI), type 2 diabetes mellitus (T2DM) and rs738409 genotype as explanatory variables. ResultsNon-obese NAFLD subjects had a higher rs738409 GG genotype than obese NAFLD. Multiple logistic regression analysis indicated that the odds ratios of T2DM and rs738409 GG genotype for NAFLD were higher in non-obese than in obese groups. In non-obese NAFLD, rs738409 GG genotype was associated with lobular inflammation, hepatocyte ballooning and NAFLD activity score. In obese NAFLD, BMI and T2DM but not rs738409 GG genotype were associated with severity of histology. ConclusionWe demonstrated that the risk factors for the development and progression of NAFLD were different between non-obese and obese patients and that PNPLA3 rs738409 was strongly associated with the development and progression of non-obese NAFLD.
引用
收藏
页码:1011 / 1018
页数:8
相关论文
共 50 条
  • [21] Non-alcoholic fatty liver disease in non-obese individuals: Prevalence, pathogenesis and treatment
    Molina-Molina, Emilio
    Krawczyk, Marcin
    Stachowska, Ewa
    Lammert, Frank
    Portincasa, Piero
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2019, 43 (06) : 638 - 645
  • [22] Therapeutic Effect of Metformin on Chemerin in Non-Obese Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
    Zhuang Xianghua
    Sun Fudun
    Li Liang
    Jiang Dongqing
    Li Xiaobo
    Sun Aili
    Pan Zhe
    Lou Nengjun
    Zhang Liang
    Lou Fuchen
    CLINICAL LABORATORY, 2015, 61 (10) : 1409 - 1414
  • [23] Prevalence of and risk factors for non-alcoholic fatty liver disease in a non-obese Japanese population, 2011–2012
    Kenichi Nishioji
    Yoshio Sumida
    Mai Kamaguchi
    Naomi Mochizuki
    Masao Kobayashi
    Takeshi Nishimura
    Kanji Yamaguchi
    Yoshito Itoh
    Journal of Gastroenterology, 2015, 50 : 95 - 108
  • [24] Genetic and Environmental Susceptibility to Non-Alcoholic Fatty Liver Disease
    Day, Christopher Paul
    DIGESTIVE DISEASES, 2010, 28 (01) : 255 - 260
  • [25] Risk factors and metabolic abnormality of patients with non-alcoholic fatty liver disease: Either non-obese or obese Chinese population
    Shou-Wu Lee
    Teng-Yu Lee
    Sheng-Shun Yang
    Chun-Fang Tung
    Hong-Zen Yeh
    Chi-Sen Chang
    Hepatobiliary & Pancreatic Diseases International, 2018, 17 (01) : 45 - 48
  • [26] Risk factors and metabolic abnormality of patients with non-alcoholic fatty liver disease: Either non-obese or obese Chinese population
    Lee, Shou-Wu
    Lee, Teng-Yu
    Yang, Sheng-Shun
    Tung, Chun-Fang
    Yeh, Hong-Zen
    Chang, Chi-Sen
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2018, 17 (01) : 45 - 48
  • [27] The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease
    Nakamuta, Makoto
    Kohjima, Motoyuki
    Higuchi, Nobito
    Kato, Masaki
    Kotoh, Kazuhiro
    Yoshimoto, Tsuyoshi
    Yada, Masayoshi
    Yada, Ryoko
    Takemoto, Ryosuke
    Fukuizumi, Kunitaka
    Harada, Naohiko
    Taketomi, Akinobu
    Maehara, Yoshihiko
    Nakashima, Manabu
    Enjoji, Munechika
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2008, 22 (05) : 663 - 667
  • [28] Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease
    Wong, Vincent Wai-Sun
    Wong, Grace Lai-Hung
    Chan, Ruth Suk-Mei
    Shu, Sally She-Ting
    Cheung, Bernice Ho-Ki
    Li, Liz Sin
    Chim, Angel Mei-Ling
    Chan, Carmen Ka-Man
    Leung, Julie Ka-Yu
    Chu, Winnie Chiu-Wing
    Woo, Jean
    Chan, Henry Lik-Yuen
    JOURNAL OF HEPATOLOGY, 2018, 69 (06) : 1349 - 1356
  • [29] Lifestyle Interventions for Non-Obese Patients Both with, and at Risk, of Non-Alcoholic Fatty Liver Disease
    Zhang, Xin-Lei
    Wang, Ting-Yao
    Targher, Giovanni
    Byrne, Christopher D.
    Zheng, Ming-Hua
    DIABETES & METABOLISM JOURNAL, 2022, 46 (03) : 391 - 401
  • [30] Can Diet Help Non-Obese Individuals with Non-Alcoholic Fatty Liver Disease (NAFLD)?
    Merchant, Hamid A.
    JOURNAL OF CLINICAL MEDICINE, 2017, 6 (09)